VolitionRx Ltd Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details Narrative) - USD ($)				6 Months Ended
Subsequent Events (Details Narrative) - USD ($)	Jan. 13, 2024	Jul. 13, 2023	Jul. 05, 2023	Jun. 30, 2023	Aug. 03, 2023	Jul. 28, 2023	Dec. 31, 2022
Common stock, shares issued				78,136,364			57,873,379
Total compensation expense				$ 724,339
Restricted Stock Units [Member]
Total compensation expense				$ 393,663
Restricted Stock Units [Member] \| Subsequent Event [Member]
Vesting period description			The RSUs are further subject to a 3-year time based vesting schedule, vesting in three equal installments on each of October 4, 2023, October 4, 2024 and October 4, 2025
RSUs, vested			490,500
Total aggregate RSUs, vested					208,809
Common stock, shares issued		14,000			167,809
Common stock, shares withheld for taxes					41,000
First Vesting date			Oct. 04, 2022
Total compensation expense		$ 18,480
Restricted Stock Units [Member] \| Subsequent Event [Member] \| July 13, 2023 [Member]
Third vesting date		Jul. 13, 2026
Second RSUs vested	21,583
Common stock, shares issued		43,165
First Vesting date		Jul. 13, 2024
First RSUs vested	21,582
Total compensation expense		$ 56,978
Restricted Stock Units [Member] \| 2015 Equity Incentive Plan [Member] \| Subsequent Event [Member]
Common stock, shares issued						14,000